Ali J. Olyaei
PharmD
Division of Nephrology and Hypertension
Oregon State University and Oregon Health & Science University
3181 SW Sam Jackson Park Road
Name/email consistency: high
- The old and new methods of assessing kidney function. Steffl, J.L., Bennett, W., Olyaei, A.J. J. Clin. Pharmacol (2012)
- The efficacy and safety of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in chronic kidney disease, dialysis, and transplant patients. Olyaei, A., Greer, E., Delos Santos, R., Rueda, J. Clin. J. Am. Soc. Nephrol (2011)
- Drug dosing in the elderly patients with chronic kidney disease. Olyaei, A.J., Bennett, W.M. Clin. Geriatr. Med. (2009)
- Cardiovascular complications of immunosuppressive agents in renal transplant recipients. Olyaei, A.J., Demattos, A.M., Bennett, W.M. Expert. Opin. Drug. Saf (2005)
- Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Olyaei, A.J., de Mattos, A.M., Bennett, W.M. Curr. Opin. Crit. Care (2001)
- Renal toxicity of protease inhibitors. Olyaei, A.J., deMattos, A.M., Bennett, W.M. Curr. Opin. Nephrol. Hypertens. (2000)